In human, MIF was shown to be expressed in different stages of human atherosclerosis [11, 18], markedly upregulated in vulnerable atheromatous plaques, and was associated with the weakening of the fibrous cap [19]. The gene discussed is MIF; the disease is atherosclerosis.